Multicenter, Randomized Study of the Effectiveness of Basiliximab in Avoiding Addition of Steroids to Cyclosporine A Monotherapy in Renal Transplant Recipients

Autor: Parrott, Neil R., Hammad, Abdel Q., Watson, Christopher J.E., Lodge, J Peter A., Andrews, Christopher D.
Zdroj: Transplantation; February 2005, Vol. 79 Issue: 3 p344-348, 5p
Abstrakt: Steroid therapy is associated with an increased risk of cardiovascular events and well-documented adverse effects, but two thirds of patients initiated on monotherapy with cyclosporine A (CsA) microemulsion require addition of steroids.
Databáze: Supplemental Index